1. Home
  2. NSP vs NEO Comparison

NSP vs NEO Comparison

Compare NSP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$36.84

Market Cap

1.1B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
NEO
Founded
1986
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
NSP
NEO
Price
$36.84
$11.50
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$47.67
$13.38
AVG Volume (30 Days)
794.8K
2.4M
Earning Date
04-30-2026
04-28-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$6,812,000,000.00
N/A
Revenue This Year
$3.45
$10.63
Revenue Next Year
$6.95
$9.73
P/E Ratio
$38.76
N/A
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$4.72
52 Week High
$63.30
$13.74

Technical Indicators

Market Signals
Indicator
NSP
NEO
Relative Strength Index (RSI) 57.71 65.42
Support Level $34.14 $11.49
Resistance Level $38.30 $11.62
Average True Range (ATR) 2.41 0.63
MACD -0.13 -0.02
Stochastic Oscillator 68.40 88.69

Price Performance

Historical Comparison
NSP
NEO

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: